The Molecular Biology of Prostate Cancer Stem Cells: From the Past to the Future
International Journal of Molecular Sciences · 19.04.2023 · 24 (8) · 7482
DOI: 10.3390/ijms24087482 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.04.2023. Verfasst von Yong Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, China. Hauptthemen laut MEDLINE: Prostate, Prostatic Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sichuan Science and Technology Program.
Abstract (Originalsprache)
Prostate cancer (PCa) continues to rank as the second leading cause of cancer-related mortality in western countries, despite the golden treatment using androgen deprivation therapy (ADT) or anti-androgen therapy. With decades of research, scientists have gradually realized that the existence of prostate cancer stem cells (PCSCs) successfully explains tumor recurrence, metastasis and therapeutic failure of PCa. Theoretically, eradication of this small population may improve the efficacy of current therapeutic approaches and prolong PCa survival. However, several characteristics of PCSCs make their diminishment extremely challenging: inherent resistance to anti-androgen and chemotherapy treatment, over-activation of the survival pathway, adaptation to tumor micro-environments, escape from immune attack and being easier to metastasize. For this end, a better understanding of PCSC biology at the molecular level will definitely inspire us to develop PCSC targeted approaches. In this review, we comprehensively summarize signaling pathways responsible for homeostatic regulation of PCSCs and discuss how to eliminate these fractional cells in clinical practice. Overall, this study deeply pinpoints PCSC biology at the molecular level and provides us some research perspectives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, China.
ORCID-Profile: Ronghao Wang
Förderung
- Sichuan Science and Technology Program
Zitieren
APA
Zhou, Y., Li, T., Jia, M., Dai, R., & Wang, R. (2023). The Molecular Biology of Prostate Cancer Stem Cells: From the Past to the Future. International Journal of Molecular Sciences, 24(8), 7482. https://doi.org/10.3390/ijms24087482
Vancouver
Zhou Y, Li T, Jia M, Dai R, Wang R. The Molecular Biology of Prostate Cancer Stem Cells: From the Past to the Future. International Journal of Molecular Sciences. 2023;24(8):7482. doi:10.3390/ijms24087482
BibTeX
@article{Zhou2023,
author = {Zhou, Yong and Li, Tian and Jia, Man and Dai, Rongyang and Wang, Ronghao},
title = {The Molecular Biology of Prostate Cancer Stem Cells: From the Past to the Future},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {8},
pages = {7482},
doi = {10.3390/ijms24087482}
}
EUVIMED